FOXA transcription factors modulate epithelial integrity and inflammation in allergic asthma models

This systematic review synthesizes evidence on FOXA transcription factors (FOXA1, FOXA2, FOXA3) in the respiratory system, particularly regarding allergic asthma pathogenesis. The review describes biological mechanisms rather than reporting on a specific clinical trial population, intervention, or comparator. No sample size, setting, or follow-up duration is reported.

In healthy lung models, FOXA1 and FOXA2 help maintain epithelial integrity and promote ciliated cell development. FOXA2 appears to suppress Th2 cell differentiation, goblet cell metaplasia, and mucus overproduction. During allergic airway inflammation, the review notes that FOXA2 expression decreases while FOXA3 expression is induced by Th2 cytokines.

The consequence of this dysregulation is described as a disruption of epithelial cell homeostasis and amplification of allergic inflammation, potentially contributing to airway remodeling. No quantitative effect sizes, absolute numbers, p-values, or confidence intervals are reported for these mechanistic observations. Safety, adverse events, and tolerability data are not reported, as the review focuses on molecular pathways.

Key limitations include significant gaps in current understanding. The authors note insufficient knowledge about the context-specific regulation of FOXA isoforms, their interplay with cytokine signaling pathways, and the translational relevance to therapeutic strategies in asthma. The practice relevance is not established, as this is a preclinical mechanistic review. The findings describe FOXA factors as modulators within a pathogenic process but do not establish definitive causation.